Dianna Marr

ThermoGenesis (United States)

Papers

1

Total Citations

5

H-Index

1

About

Dianna Marr is a researcher whose work centers on the optimization and validation of cord blood stem cell processing technologies, a critical area in regenerative medicine and hematopoietic transplantation. Her most notable contribution is the 2007 study, "Validation study of mononuclear cell recovery using the AXP™ AutoXpress™ Platform," which systematically evaluated the performance of this automated system for processing umbilical cord blood prior to cryopreservation. By demonstrating the platform’s ability to achieve consistent, high-yield mononuclear cell recovery within a functionally closed, sterile environment, Marr provided essential evidence supporting the adoption of automated processing over manual methods. This work, cited 5 times, has helped establish benchmarks for quality control in cord blood banking, directly impacting the reliability of stem cell products for clinical use. Her research underscores the importance of standardized, microprocessor-controlled systems in improving the efficiency and safety of stem cell preservation, making her a key figure in advancing bioprocessing technologies for transplantation and cellular therapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
110: Validation study of mononuclear cell recovery using the AXP™ AutoXpress™ Platform
5 citations · 2007
📈 Most Prolific Year: 2007 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: ThermoGenesis (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago